Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Maxim E. Rozanov"'
Autor:
Peter Devilee, Ari Hirvonen, Ekatherina Sh. Kuligina, Daria N. Ponomariova, Nathalia V. Mitiushkina, Alexandr V. Togo, Vladimir A. Shutkin, Evgeny Levchenko, Sergiu I. Brenister, Evgeny N. Imyanitov, Maxim E. Rozanov, Yulia M. Ulybina, Alexandr O. Ivantsov, Boris Zhivotovsky
Publikováno v:
Cancer Letters. 278:183-191
Apoptosis plays a role in the elimination of DNA-damaged cells thus protecting the host from cancer development. Some data indicate that normal variations within the sequence of apoptotic genes may lead to suboptimal apoptotic capacity and therefore
Autor:
Adel F Urmancheyeva, Alexandr V. Togo, Nadezhda Yu Krylova, Oksana S Lobeiko, Maxim E. Rozanov, Madina M. Gergova, Anna P. Sokolenko, Evgeny N. Imyanitov, Natalia V. Mitiushkina, Tatiana V Porhanova, Aglaya G. Iyevleva, Sergey Ya Maximov
Publikováno v:
Hereditary Cancer in Clinical Practice
Hereditary Cancer in Clinical Practice, Vol 4, Iss 4, Pp 193-196 (2006)
Hereditary Cancer in Clinical Practice, Vol 4, Iss 4, Pp 193-196 (2006)
The BRCA1 4153delA allele is frequently referred to as the Russian founder mutation, as it was initially detected in several cancer families from Moscow. Our earlier studies have demonstrated 1% occurrence of BRCA1 4153delA heterozygosity in familial
Autor:
Cees J. Cornelisse, Evgeny N. Imyanitov, Oleg L. Chagunava, Ekatherina Sh. Kuligina, Dmitry Yu. Trofimov, Matsko De, Vladimir Semiglazov, Peter Devilee, Natalia V. Mitiushkina, Aglaya G. Iyevleva, Elena M. Bit-Sava, Yulia M. Ulibina, Anna P. Sokolenko, Elena V. Chekmariova, Alexandr V. Togo, Konstantin G. Buslov, Maxim E. Rozanov, Evgeny N. Suspitsin
Publikováno v:
European Journal of Cancer. 42:1380-1384
BRCA1 5382insC variant was repeatedly detected in Jewish breast cancer (BC) families residing in USA and Israel as well as in non-Jewish familial BC patients from Poland, Latvia, Hungary, Russia and some other European countries. However, the distrib
Autor:
Vladimir Semiglazov, Evgeny N. Imyanitov, Anna P. Sokolenko, Dmitry A. Voskresenskiy, Matsko De, Yulia M. Ulibina, Natalia V. Mitiushkina, Maxim E. Rozanov, Aglaya G. Iyevleva, Oleg L. Chagunava, Peter Devilee, Alexandr V. Togo, Konstantin G. Buslov, Elena V. Chekmariova, Cees J. Cornelisse
Publikováno v:
Breast Cancer Research and Treatment. 100:99-102
This study was aimed to assess the role of CHEK2 1100delC mutation in breast cancer (BC) predisposition in Russia. The 1100delC allele was detected in 14/660 (2.1%) unilateral BC cases and in 8/155 (5.2%) patients with the bilateral form of the disea
Autor:
Natalia V. Mitiushkina, Alexandr V. Togo, Evgeny N. Imyanitov, Konstantin G. Buslov, Anna P. Sokolenko, Dmitry A. Voskresenskiy, Elena M. Bit-Sava, Elena V. Chekmariova, Vladimir Semiglazov, Aglaya G. Iyevleva, E. S. Shilov, Maxim E. Rozanov, Cees J. Cornelisse, Natalia Yu. Sherina, Oleg L. Chagunava, Peter Devilee
Publikováno v:
Familial cancer. 6(3)
Previous studies indicate that founder mutations may play a noticeable role in breast cancer (BC) predisposition in Russia. Here we performed a systematic analysis of eight recurrent mutations in 302 BC cases (St.-Petersburg, Russia), which were sele